Peter G. Kremsner

Research interests

Publications

• Codiversification of gut microbiota with humans

  Science · 2022 · https://doi.org/10.1126/science.abm7759

• Host genetic factors determining COVID-19 susceptibility and severity

  EBioMedicine · 2021 · https://doi.org/10.1016/j.ebiom.2021.103629

• Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

  The Lancet Infectious Diseases · 2021 · https://doi.org/10.1016/s1473-3099(21)00677-0

• Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

  Nature Communications · 2021 · https://doi.org/10.1038/s41467-021-22446-z

• Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible

  International Journal of Infectious Diseases · 2020 · https://doi.org/10.1016/j.ijid.2020.08.076

• Sterile protection against human malaria by chemoattenuated PfSPZ vaccine

  Nature · 2017 · 10.1038/nature21060

• A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms

  New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1513137

• Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres

  Malaria Journal · 2015 · https://doi.org/10.1186/s12936-015-0628-0

• Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

  New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1502924

• Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

  New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1505819

• Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

  The Lancet Infectious Diseases · 2015 · https://doi.org/10.1016/s1473-3099(15)00239-x

• Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

  The Lancet · 2015 · https://doi.org/10.15496/publikation-6508

• Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness

  The Journal of Infectious Diseases · 2014 · 10.1093/infdis/jit839

• A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer

  EBioMedicine · 2014 · 10.1016/j.ebiom.2014.11.010

• Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials

  The Lancet · 2009 · https://doi.org/10.1016/s0140-6736(09)61258-7

• Severe falciparum malaria in Gabonese children: clinical and laboratory features.

  Malaria Journal · 2005 · 10.1186/1475-2875-4-1

• Antimalarial combinations

  The Lancet · 2004 · 10.1016/s0140-6736(04)16680-4

• Long‐Term Treatment of Intestinal Helminths Increases Mite Skin‐Test Reactivity in Gabonese Schoolchildren

  The Journal of Infectious Diseases · 2004 · 10.1086/381767

• Fosmidomycin, a Novel Chemotherapeutic Agent for Malaria

  Antimicrobial Agents and Chemotherapy · 2003 · 10.1128/aac.47.2.735-738.2003

• Fosmidomycin for malaria

  The Lancet · 2002 · https://doi.org/10.1016/s0140-6736(02)11860-5

• Allergy, Parasites, and the Hygiene Hypothesis

  Science · 2002 · 10.1126/science.296.5567.490

• Comparison of methods for the rapid laboratory assessment of children with malaria.

  American Journal of Tropical Medicine and Hygiene · 2001 · 10.4269/ajtmh.2001.65.599

• Low Interleukin-12 Activity in Severe Plasmodium falciparum Malaria

  Infection and Immunity · 2000 · 10.1128/iai.68.7.3909-3915.2000

• A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses

  Nature Medicine · 2000 · 10.1038/76272

• High recombination rate in natural populations of Plasmodium falciparum

  Proceedings of the National Academy of Sciences · 1999 · https://doi.org/10.1073/pnas.96.8.4506

• The Role of Red Blood Cell Polymorphisms in Resistance and Susceptibility to Malaria

  Clinical Infectious Diseases · 1999 · https://doi.org/10.1086/515193

• Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria

  The Lancet · 1997 · 10.1016/s0140-6736(97)02255-1

Current projects

No projects listed.